Study summary

The objective of this study was to evaluate the safety profile of ELIGARD® in ethnic Asian prostate cancer patients.

Additional Study Details

Phase
Phase 4
Product
leuprorelin
Product
Leuprolide
Type
Interventional
Masking
None (Open Label)
Enrollment number
107
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English
Protocol
Available Language(s): English
Statistical Analysis Plan (SAP)
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study of ELIGARD® in hormone-dependent prostate cancer patients? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site VN08002
    Ho Chi Minh City, Vietnam
    Completed
    Site PH04002
    San Juan, Metro Manila, Philippines
    Completed
    Site MY03001
    Kuala Lumpur, Kuala Lumpur, Malaysia
    Completed
    Site SG05001
    Singapore, Singapore
    Completed
    Site TH07004
    Hat Yai, Songkhla, Thailand
    Completed
    Site TW06001
    Taichung, Taiwan, Province of China
    Completed
    Site TW06003
    Taipei, Taiwan, Province of China
    Completed
    Site SG05002
    Singapore, Singapore
    Completed
    Site TH07001
    Muang, Chiang Mai, Thailand
    Completed
    Site TW06002
    Taichung, Taiwan, Province of China
    Completed
    Site PH04001
    Makati City, Metro Manila, Philippines
    Withdrawn
    Site TH07002
    Bangkok, Bangkok, Thailand
    Completed
    Site HK01002
    Hong Kong, Hong Kong
    Completed
    Site HK01001
    Hong Kong, Hong Kong
    Completed
    Site PH04003
    Manila, Metro Manila, Philippines
    Completed
    Site TH07003
    Bangkok, Bangkok, Thailand
    Completed
    Site MY03002
    Batu Caves, Selangor, Malaysia
    Completed
    Site SG05003
    Singapore, Singapore
    Completed
    Site ID02001
    Jakarta, DKI Jakarta, Indonesia
    Completed
    Site VN08001
    Ho Chi Minh City, Vietnam

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?